Collateral for a security interest recorded Oct 19, 2022 (Orbimed Royalty & Credit Opportunities IV, LP).
Term ends no later than Feb 28, 2027 · Medium confidence
20-year base term ended Oct 29, 2023
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Held by Transave, LLC
Filed Jul 19, 2005 as application 11/185,448 · Granted May 18, 2010
Base term plus 1218 days of patent term adjustment (USPTO delay)
Today
2003
2027
Clock starts
Oct 29, 2003
Oct 29, 2003
Ends no later than
Feb 28, 2027
Feb 28, 2027
Granted
May 18, 2010
May 18, 2010
base term
patent term adjustment
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,218
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
25
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 1218 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. All three maintenance fees are recorded paid; no more fees are due. Confidence: Medium. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 29, 2003, when application 10/696,389, the earliest non-provisional in its chain, was filed (this one was filed Jul 19, 2005) | Oct 29, 2023 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1218 days, USPTO patent term adjustment record | Feb 28, 2027 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Feb 28, 2027 | Medium confidence |
This family
| US 7,544,369 | Term ended Jun 2025 | Jun 2025 |
| Application 11/023,971 | Abandoned not computed | not computed |
| US 7,718,189 | this patent no later than Feb 2027 | no later than Feb 2027 |
| US 7,879,351 | In force no later than Nov 2026 | no later than Nov 2026 |
| Application PCT/US2006/027859 | PCT application no patent term | no patent term |
| Application PCT/US2007/008404 | PCT application no patent term | no patent term |
| Application 12/424,177 | Abandoned not computed | not computed |
| US 8,802,137 | Term ended Apr 2024 | Apr 2024 |
8 of 25 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Mar 26, 2008 Reel 20703, frame 491 | Boni, Lawrence T.; Miller, Brian S.; Malinin, Vladimir; Li, Xingong | Transave, Inc. | Assignment of Assignor's Interest |
| Aug 7, 2013 Reel 30959, frame 547 | Transave, Inc. | Transave, LLC | Merger |
| Aug 7, 2013 Reel 30959, frame 682 | Transave, LLC | Insmed Incorporated | Assignment of Assignor's Interest |
| Aug 12, 2021 Reel 57162, frame 137 | Boni, Lawrence T.; Miller, Brian S.; Malinin, Vladimir | Transave, Inc. | Assignment of Assignor's Interest |
| Aug 12, 2021 Reel 57162, frame 462 | Transave, Inc. | Transave, LLC | Merger |
| Oct 19, 2022 Reel 61727, frame 39 | Insmed Incorporated | Orbimed Royalty & Credit Opportunities IV, LP | Second Lien Patent Security Agreement |
| Oct 20, 2022 Reel 61735, frame 875 | Insmed Incorporated | Biopharma Credit PLC | Patent Security Agreement |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Feb 2027
Term ends no later than Feb 28, 2027. No further fees fall due before then
Note
A terminal disclaimer is on file and its reference is not resolved. No cap is applied and none is guessed
Note
The 1218 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Open question
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Feb 28, 2027. We will not guess the cap.
Citations
99
later US patents cite this one
That is top 10% of utility patents granted in 2010 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
This computed term ends no later than the date shown; an unresolved terminal disclaimer may end it earlier. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.